In addition, because HDAC6 inhibitors disrupt gliomagenesis by converting the phenotype of actively dividing glioma cells to more differentiated states [5,7], we examined whether this differentiation is also dependent on the presence of cilia. This evidence concerns the gene HDAC6 and central nervous system cancer.